Citation: Re. Wittes et O. Yoder, ONE COMMUNITY - THE B.-CHEVALIER-LECTURE, HELD AT THE EORTC NEW DRUGSMEETING, LUGANO, SWITZERLAND, 19-21 JUNE 1997, Annals of oncology, 9(3), 1998, pp. 251-254
Citation: R. Little et al., VINBLASTINE FOR RECURRENT HODGKINS-DISEASE FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANT, Journal of clinical oncology, 16(2), 1998, pp. 584-588
Citation: Eg. Feigal et al., AIDS MALIGNANCY PROGRAM - NEW INITIATIVES FROM THE NATIONAL-CANCER-INSTITUTE, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 58-58
Authors:
LONGO DL
GLATSTEIN E
DUFFEY PL
YOUNG RC
IHDE DC
BASTIAN AW
WILSON WH
WITTES RE
JAFFE ES
HUBBARD SM
DEVITA VT
Citation: Dl. Longo et al., ALTERNATING MOPP AND ABVD CHEMOTHERAPY PLUS MANTLE-FIELD RADIATION-THERAPY IN PATIENTS WITH MASSIVE MEDIASTINAL HODGKINS-DISEASE, Journal of clinical oncology, 15(11), 1997, pp. 3338-3346
Authors:
WEINSTEIN JN
MYERS TG
OCONNOR PM
FRIEND SH
FORNACE AJ
KOHN KW
FOJO T
BATES SE
RUBINSTEIN LV
ANDERSON NL
BUOLAMWINI JK
VANOSDOL WW
MONKS AP
SCUDIERO DA
SAUSVILLE EA
ZAHAREVITZ DW
BUNOW B
VISWANADHAN VN
JOHNSON GS
WITTES RE
PAULL KD
Citation: Jn. Weinstein et al., AN INFORMATION-INTENSIVE APPROACH TO THE MOLECULAR PHARMACOLOGY OF CANCER, Science, 275(5298), 1997, pp. 343-349
Authors:
WHITCUP SM
STARKVANCS V
WITTES RE
SOLOMON D
PODGOR MJ
NUSSENBLATT RB
CHAN CC
Citation: Sm. Whitcup et al., ASSOCIATION OF INTERLEUKIN-10 IN THE VITREOUS AND CEREBROSPINAL-FLUIDAND PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA, Archives of ophthalmology, 115(9), 1997, pp. 1157-1160
Authors:
STERNAS L
JANIK JE
DUFFEY PL
GOCKE C
REYNOLDS CW
WITTES RE
KWAK LW
Citation: L. Sternas et al., EARLY RESULTS OF A CLINICAL-TRIAL OF THERAPEUTIC VACCINATION WITH IG IDIOTYPE ANTIGEN FOR DE-NOVO FOLLICULAR LYMPHOMA, Blood, 88(10), 1996, pp. 2677-2677
Authors:
WILSON WH
KINGMA DW
RAFFELD M
WITTES RE
JAFFE ES
Citation: Wh. Wilson et al., ASSOCIATION OF LYMPHOMATOID GRANULOMATOSIS WITH EPSTEIN-BARR VIRAL-INFECTION OF B-LYMPHOCYTES AND RESPONSE TO INTERFERON-ALPHA-2B, Blood, 87(11), 1996, pp. 4531-4537
Authors:
WILSON WH
JAMISDOW C
BRYANT G
BALIS FM
KLECKER RW
BATES SE
CHABNER BA
STEINBERG SM
KOHLER DR
WITTES RE
Citation: Wh. Wilson et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY, Journal of clinical oncology, 13(8), 1995, pp. 1985-1994
Authors:
WILSON WH
BATES SE
FOJO A
BRYANT G
ZHAN Z
REGIS J
WITTES RE
JAFFE ES
STEINBERG SM
HERDT J
CHABNER BA
Citation: Wh. Wilson et al., CONTROLLED TRIAL OF DEXVERAPAMIL, A MODULATOR OF MULTIDRUG-RESISTANCE, IN LYMPHOMAS REFRACTORY TO EPOCH CHEMOTHERAPY, Journal of clinical oncology, 13(8), 1995, pp. 1995-2004
Authors:
TERUYAFELDSTEIN J
WILSON WH
HARRIS C
STEINBERG SM
WITTES RE
CHABNER BA
BRYANT GA
JAFFE ES
RAFFELD M
Citation: J. Teruyafeldstein et al., P53 EXPRESSION IS ASSOCIATED WITH POOR RESPONSE AND SURVIVAL TO EPOCHCHEMOTHERAPY IN RELAPSED NON-HODGKINS-LYMPHOMA, Laboratory investigation, 72(1), 1995, pp. 121-121
Authors:
STEFANOVA I
OSHAUGHNESSY J
ZUJEWSKI J
COWAN K
REED E
BOLEN JB
WITTES RE
HORAK ID
Citation: I. Stefanova et al., MOLECULAR MECHANISMS OF CANCER-ASSOCIATED IMMUNOSUPPRESSION - PARADIGM OF T-CELL REGULATION, Blood, 86(10), 1995, pp. 2873-2873
Authors:
SAUSVILLE EA
HEADLEE D
STETLERSTEVENSON M
JAFFE ES
SOLOMON D
FIGG WD
HERDT J
KOPP WC
RAGER H
STEINBERG SM
GHETIE V
SCHINDLER J
UHR J
WITTES RE
VITETTA ES
Citation: Ea. Sausville et al., CONTINUOUS-INFUSION OF THE ANTI-CD22 IMMUNOTOXIN IGG-RFB4-SMPT-DGA INPATIENTS WITH B-CELL LYMPHOMA - A PHASE-I STUDY, Blood, 85(12), 1995, pp. 3457-3465
Authors:
WILSON WH
BERG SL
BRYANT G
WITTES RE
BATES S
FOJO A
STEINBERG SM
GOLDSPIEL BR
HERDT J
OSHAUGHNESSY J
BALIS FM
CHABNER BA
Citation: Wh. Wilson et al., PACLITAXEL IN DOXORUBICIN-REFRACTORY OR MITOXANTRONE-REFRACTORY BREAST-CANCER - A PHASE I II TRIAL OF 96-HOUR INFUSION/, Journal of clinical oncology, 12(8), 1994, pp. 1621-1629
Authors:
LONGO DL
DUFFEY PL
JAFFE ES
RAFFELD M
HUBBARD SM
FISHER RI
WITTES RE
DEVITA VT
YOUNG RC
Citation: Dl. Longo et al., DIFFUSE SMALL NONCLEAVED-CELL, NON-BURKITTS LYMPHOMA IN ADULTS - A HIGH-GRADE LYMPHOMA RESPONSIVE TO PROMACE-BASED COMBINATION CHEMOTHERAPY, Journal of clinical oncology, 12(10), 1994, pp. 2153-2159
Authors:
WILSON WH
BRYANT G
BATES S
FOJO A
WITTES RE
STEINBERG SM
KOHLER DR
JAFFE ES
HERDT J
CHESON BD
CHABNER BA
Citation: Wh. Wilson et al., EPOCH CHEMOTHERAPY - TOXICITY AND EFFICACY IN RELAPSED AND REFRACTORYNON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 11(8), 1993, pp. 1573-1582
Authors:
CHABNER BA
BATES SE
FOJO AT
WITTES RE
BRYANT GA
HERDT JRL
WILSON WH
Citation: Ba. Chabner et al., STUDIES OF DRUG-RESISTANCE IN MALIGNANT-LYMPHOMA, International journal of radiation oncology, biology, physics, 27, 1993, pp. 124-124